139 related articles for article (PubMed ID: 8382319)
21. Post-translational modifications of poliovirus proteins.
Urzainqui A; Carrasco L
Biochem Biophys Res Commun; 1989 Jan; 158(1):263-71. PubMed ID: 2536278
[TBL] [Abstract][Full Text] [Related]
22. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.
Marc D; Girard M; van der Werf S
J Gen Virol; 1991 May; 72 ( Pt 5)():1151-7. PubMed ID: 1851815
[TBL] [Abstract][Full Text] [Related]
23. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
[TBL] [Abstract][Full Text] [Related]
24. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain.
Macadam AJ; Ferguson G; Arnold C; Minor PD
J Virol; 1991 Oct; 65(10):5225-31. PubMed ID: 1654440
[TBL] [Abstract][Full Text] [Related]
25. A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation.
Blair WS; Hwang SS; Ypma-Wong MF; Semler BL
J Virol; 1990 Apr; 64(4):1784-93. PubMed ID: 2157059
[TBL] [Abstract][Full Text] [Related]
26. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318
[TBL] [Abstract][Full Text] [Related]
27. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.
Mattion NM; Reilly PA; Camposano E; Wu SL; DiMichele SJ; Ishizaka ST; Fantini SE; Crowley JC; Weeks-Levy C
J Virol; 1995 Aug; 69(8):5132-7. PubMed ID: 7609083
[TBL] [Abstract][Full Text] [Related]
28. trans rescue of a mutant poliovirus RNA polymerase function.
Charini WA; Burns CC; Ehrenfeld E; Semler BL
J Virol; 1991 May; 65(5):2655-65. PubMed ID: 1850039
[TBL] [Abstract][Full Text] [Related]
29. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.
Ypma-Wong MF; Semler BL
J Virol; 1987 Oct; 61(10):3181-9. PubMed ID: 3041039
[TBL] [Abstract][Full Text] [Related]
30. Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.
Liao S; Racaniello V
J Virol; 1997 Dec; 71(12):9770-7. PubMed ID: 9371643
[TBL] [Abstract][Full Text] [Related]
31. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.
Wiegers K; Uhlig H; Dernick R
Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354
[TBL] [Abstract][Full Text] [Related]
32. Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirions.
Compton SR; Nelsen B; Kirkegaard K
J Virol; 1990 Sep; 64(9):4067-75. PubMed ID: 2166805
[TBL] [Abstract][Full Text] [Related]
33. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.
Rhee SS; Hunter E
J Virol; 1987 Apr; 61(4):1045-53. PubMed ID: 3493352
[TBL] [Abstract][Full Text] [Related]
34. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Göttlinger HG; Sodroski JG; Haseltine WA
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5781-5. PubMed ID: 2788277
[TBL] [Abstract][Full Text] [Related]
35. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
Bräutigam S; Snezhkov E; Bishop DH
Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
[TBL] [Abstract][Full Text] [Related]
36. Addition of a foreign oligopeptide to the major capsid protein of poliovirus.
Colbère-Garapin F; Christodoulou C; Crainic R; Garapin AC; Candrea A
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8668-72. PubMed ID: 2460875
[TBL] [Abstract][Full Text] [Related]
37. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
Porter DC; Melsen LR; Compans RW; Morrow CD
J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
[TBL] [Abstract][Full Text] [Related]
38. The construction and characterization of poliovirus antigen chimeras presenting defined regions of the human T lymphocyte marker CD4.
Rose C; Andrews W; Ferguson M; McKeating J; Almond J; Evans D
J Gen Virol; 1994 May; 75 ( Pt 5)():969-77. PubMed ID: 8176383
[TBL] [Abstract][Full Text] [Related]
39. Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis.
Diamond SE; Kirkegaard K
J Virol; 1994 Feb; 68(2):863-76. PubMed ID: 8289389
[TBL] [Abstract][Full Text] [Related]
40. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
Burns CC; Shaw J; Campagnoli R; Jorba J; Vincent A; Quay J; Kew O
J Virol; 2006 Apr; 80(7):3259-72. PubMed ID: 16537593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
